Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 2
1988 1
1989 2
1990 5
1992 1
1993 1
1995 1
1998 1
1999 1
2000 1
2001 1
2002 3
2003 6
2004 3
2005 8
2006 7
2007 8
2008 12
2009 7
2010 8
2011 14
2012 14
2013 9
2014 22
2015 25
2016 30
2017 17
2018 21
2019 17
2020 8
2021 11
2022 10
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Minyazev
Page 1
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design.
Dorywalska M, Dushin R, Moine L, Farias SE, Zhou D, Navaratnam T, Lui V, Hasa-Moreno A, Casas MG, Tran TT, Delaria K, Liu SH, Foletti D, O'Donnell CJ, Pons J, Shelton DL, Rajpal A, Strop P. Dorywalska M, et al. Mol Cancer Ther. 2016 May;15(5):958-70. doi: 10.1158/1535-7163.MCT-15-1004. Epub 2016 Mar 4. Mol Cancer Ther. 2016. PMID: 26944918
Anomaly Detection in Time Series Data Using Reversible Instance Normalized Anomaly Transformer.
Baidya R, Jeong H. Baidya R, et al. Sensors (Basel). 2023 Nov 19;23(22):9272. doi: 10.3390/s23229272. Sensors (Basel). 2023. PMID: 38005658 Free PMC article.
For this, we introduce the reversible instance normalized anomaly transformer (RINAT). Rooted in the foundational principles of the anomaly transformer, RINAT incorporates both prior and series associations for each time point. ...
For this, we introduce the reversible instance normalized anomaly transformer (RINAT). Rooted in the foundational principles of the a …
Versatility of microbial transglutaminase.
Strop P. Strop P. Bioconjug Chem. 2014 May 21;25(5):855-62. doi: 10.1021/bc500099v. Epub 2014 Apr 17. Bioconjug Chem. 2014. PMID: 24694238 Review.
T Cell Redirecting Therapies for Cancer Treatment.
Sasu B, Chaparro-Riggers J. Sasu B, et al. Curr Cancer Drug Targets. 2016;16(1):22-33. doi: 10.2174/1568009615666150827093149. Curr Cancer Drug Targets. 2016. PMID: 26712352 Review.
Ribosomal Antibiotics: Contemporary Challenges.
Auerbach-Nevo T, Baram D, Bashan A, Belousoff M, Breiner E, Davidovich C, Cimicata G, Eyal Z, Halfon Y, Krupkin M, Matzov D, Metz M, Rufayda M, Peretz M, Pick O, Pyetan E, Rozenberg H, Shalev-Benami M, Wekselman I, Zarivach R, Zimmerman E, Assis N, Bloch J, Israeli H, Kalaora R, Lim L, Sade-Falk O, Shapira T, Taha-Salaime L, Tang H, Yonath A. Auerbach-Nevo T, et al. Antibiotics (Basel). 2016 Jun 29;5(3):24. doi: 10.3390/antibiotics5030024. Antibiotics (Basel). 2016. PMID: 27367739 Free PMC article. Review.
241 results